Kwality Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Kwality Pharma	Lincoln Pharma	Sakar Healthcare
Operational Metrics
Financials
5 yr Average ROE	25.27 %	15.1 %	8.14 %
5yr average Equity Multiplier	1.96	1.26	1.76
5yr Average Asset Turnover Ratio	1.05	0.82	0.45
5yr Avg Net Profit Margin	11.66 %	14.59 %	10.03 %
Price to Book	3.22	1.37	2.87
P/E	19.02	12.24	44.6
5yr Avg Cash Conversion Cycle	55.02 Days	-6.41 Days	18.72 Days
Inventory Days	67.04 Days	43.91 Days	51.79 Days
Days Receivable	132.46 Days	91.75 Days	53.06 Days
Days Payable	126.93 Days	128.38 Days	115.64 Days
5yr Average Interest Coverage Ratio	16.13	63.13	4.85
5yr Avg ROCE	34.73 %	19.81 %	8.92 %
5yr Avg Operating Profit Margin	23.23 %	18.35 %	24.94 %
5 yr average Debt to Equity	0.46	0.0	0.49
5yr CAGR Net Profit	21.34 %	5.76 %	10.38 %
5yr Average Return on Assets	12.96 %	11.92 %	4.54 %
Shareholdings
Promoter Holding	54.83 %	49.78 %	52.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.38 %	5.7 %	-9.24 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Kwality Pharma	Lincoln Pharma	Sakar Healthcare
Segment Break-Up	Segment Break-Up Formulations 100.0	-	-
Formulations Breakup	Formulations Breakup Others 100	-	-
Location Wise Break-Up	Location Wise Break-Up India 47.21 Rest of the World 0 International 0 Domestic 0 Others 52.79	Location Wise Break-Up Rest of the World 68.6 International 0 Domestic 0 India 31.4	Location Wise Break-Up Rest of the World 0 International 55.48 Domestic 44.52 India 0